nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosiglitazone—SLCO1B1—breast cancer	0.194	0.551	CbGaD
Rosiglitazone—Tripelennamine—Tamoxifen—breast cancer	0.115	1	CrCrCtD
Rosiglitazone—PTGS1—breast cancer	0.0724	0.205	CbGaD
Rosiglitazone—CYP2A6—Letrozole—breast cancer	0.0531	0.172	CbGbCtD
Rosiglitazone—CYP2D6—breast cancer	0.0493	0.14	CbGaD
Rosiglitazone—ALB—breast cancer	0.0369	0.105	CbGaD
Rosiglitazone—CYP1A2—Anastrozole—breast cancer	0.0181	0.0584	CbGbCtD
Rosiglitazone—CYP1A2—Toremifene—breast cancer	0.0165	0.0534	CbGbCtD
Rosiglitazone—CYP2C9—Anastrozole—breast cancer	0.0163	0.0526	CbGbCtD
Rosiglitazone—CYP2A6—Tamoxifen—breast cancer	0.0158	0.0511	CbGbCtD
Rosiglitazone—CYP2C8—Lapatinib—breast cancer	0.0156	0.0503	CbGbCtD
Rosiglitazone—SLCO1B1—Irinotecan—breast cancer	0.0141	0.0457	CbGbCtD
Rosiglitazone—CYP2C19—Lapatinib—breast cancer	0.0131	0.0422	CbGbCtD
Rosiglitazone—CYP2C9—Idarubicin—breast cancer	0.0123	0.0399	CbGbCtD
Rosiglitazone—CYP2C8—Raloxifene—breast cancer	0.0118	0.0381	CbGbCtD
Rosiglitazone—CYP2A6—Fluorouracil—breast cancer	0.0117	0.0377	CbGbCtD
Rosiglitazone—CYP2D6—Idarubicin—breast cancer	0.0113	0.0364	CbGbCtD
Rosiglitazone—CYP2C8—Tamoxifen—breast cancer	0.0078	0.0252	CbGbCtD
Rosiglitazone—ALB—Irinotecan—breast cancer	0.00775	0.025	CbGbCtD
Rosiglitazone—SLCO1B1—Methotrexate—breast cancer	0.00749	0.0242	CbGbCtD
Rosiglitazone—ALB—Fluorouracil—breast cancer	0.00743	0.024	CbGbCtD
Rosiglitazone—CYP2C9—Capecitabine—breast cancer	0.00676	0.0218	CbGbCtD
Rosiglitazone—CYP2C19—Tamoxifen—breast cancer	0.00654	0.0211	CbGbCtD
Rosiglitazone—CYP2C8—Paclitaxel—breast cancer	0.00607	0.0196	CbGbCtD
Rosiglitazone—CYP1A2—Tamoxifen—breast cancer	0.00604	0.0195	CbGbCtD
Rosiglitazone—CYP2C8—Fluorouracil—breast cancer	0.00575	0.0186	CbGbCtD
Rosiglitazone—CYP2D6—Vinorelbine—breast cancer	0.00551	0.0178	CbGbCtD
Rosiglitazone—CYP2C9—Tamoxifen—breast cancer	0.00544	0.0176	CbGbCtD
Rosiglitazone—CYP2D6—Tamoxifen—breast cancer	0.00497	0.0161	CbGbCtD
Rosiglitazone—CYP1A2—Fluorouracil—breast cancer	0.00445	0.0144	CbGbCtD
Rosiglitazone—CYP2C9—Paclitaxel—breast cancer	0.00423	0.0137	CbGbCtD
Rosiglitazone—ALB—Methotrexate—breast cancer	0.0041	0.0132	CbGbCtD
Rosiglitazone—CYP2C9—Fluorouracil—breast cancer	0.00401	0.0129	CbGbCtD
Rosiglitazone—CYP2D6—Vinblastine—breast cancer	0.00339	0.011	CbGbCtD
Rosiglitazone—CYP2D6—Doxorubicin—breast cancer	0.00209	0.00674	CbGbCtD
Rosiglitazone—ACSL4—nipple—breast cancer	0.00159	0.0636	CbGeAlD
Rosiglitazone—PPARG—Topotecan—Irinotecan—breast cancer	0.00141	1	CbGdCrCtD
Rosiglitazone—Pioglitazone—SLCO1B1—breast cancer	0.00117	0.433	CrCbGaD
Rosiglitazone—SLCO1B1—mammary gland—breast cancer	0.001	0.0401	CbGeAlD
Rosiglitazone—ACSL4—endometrium—breast cancer	0.000958	0.0384	CbGeAlD
Rosiglitazone—ACSL4—uterus—breast cancer	0.000883	0.0354	CbGeAlD
Rosiglitazone—ACSL4—pituitary gland—breast cancer	0.000867	0.0348	CbGeAlD
Rosiglitazone—ACSL4—adipose tissue—breast cancer	0.000864	0.0346	CbGeAlD
Rosiglitazone—PPARG—mammary gland—breast cancer	0.000863	0.0346	CbGeAlD
Rosiglitazone—ALB—mammary gland—breast cancer	0.00081	0.0325	CbGeAlD
Rosiglitazone—ACSL4—female reproductive system—breast cancer	0.000794	0.0318	CbGeAlD
Rosiglitazone—ACSL4—adrenal gland—breast cancer	0.000775	0.0311	CbGeAlD
Rosiglitazone—ACSL4—bone marrow—breast cancer	0.000749	0.03	CbGeAlD
Rosiglitazone—ACSL4—female gonad—breast cancer	0.000722	0.029	CbGeAlD
Rosiglitazone—PPARG—nipple—breast cancer	0.000714	0.0286	CbGeAlD
Rosiglitazone—ACSL4—endocrine gland—breast cancer	0.000672	0.0269	CbGeAlD
Rosiglitazone—PPARG—embryo—breast cancer	0.000589	0.0236	CbGeAlD
Rosiglitazone—CYP2C8—mammary gland—breast cancer	0.000569	0.0228	CbGeAlD
Rosiglitazone—CYP2C9—mammary gland—breast cancer	0.000505	0.0203	CbGeAlD
Rosiglitazone—PPARG—epithelium—breast cancer	0.000481	0.0193	CbGeAlD
Rosiglitazone—ACSL4—lymph node—breast cancer	0.000464	0.0186	CbGeAlD
Rosiglitazone—PPARG—skin of body—breast cancer	0.000457	0.0183	CbGeAlD
Rosiglitazone—CYP2A6—adipose tissue—breast cancer	0.000456	0.0183	CbGeAlD
Rosiglitazone—CYP1A2—nipple—breast cancer	0.00044	0.0177	CbGeAlD
Rosiglitazone—Pioglitazone—PTGS1—breast cancer	0.000434	0.162	CrCbGaD
Rosiglitazone—SLCO1B1—female reproductive system—breast cancer	0.000414	0.0166	CbGeAlD
Rosiglitazone—PPARG—uterus—breast cancer	0.000397	0.0159	CbGeAlD
Rosiglitazone—PPARG—adipose tissue—breast cancer	0.000389	0.0156	CbGeAlD
Rosiglitazone—PTGS1—nipple—breast cancer	0.000382	0.0153	CbGeAlD
Rosiglitazone—PPARG—female reproductive system—breast cancer	0.000357	0.0143	CbGeAlD
Rosiglitazone—SLCO1B1—endocrine gland—breast cancer	0.00035	0.014	CbGeAlD
Rosiglitazone—PPARG—adrenal gland—breast cancer	0.000349	0.014	CbGeAlD
Rosiglitazone—PPARG—bone marrow—breast cancer	0.000337	0.0135	CbGeAlD
Rosiglitazone—ALB—adrenal gland—breast cancer	0.000327	0.0131	CbGeAlD
Rosiglitazone—PPARG—female gonad—breast cancer	0.000325	0.013	CbGeAlD
Rosiglitazone—PPARG—endocrine gland—breast cancer	0.000302	0.0121	CbGeAlD
Rosiglitazone—Pioglitazone—CYP2D6—breast cancer	0.000296	0.11	CrCbGaD
Rosiglitazone—CYP2C8—endometrium—breast cancer	0.000284	0.0114	CbGeAlD
Rosiglitazone—Dofetilide—CYP3A4—breast cancer	0.000266	0.0989	CrCbGaD
Rosiglitazone—CYP2C8—pituitary gland—breast cancer	0.000257	0.0103	CbGeAlD
Rosiglitazone—PTGS1—epithelium—breast cancer	0.000257	0.0103	CbGeAlD
Rosiglitazone—Pioglitazone—CYP3A4—breast cancer	0.000254	0.0943	CrCbGaD
Rosiglitazone—PTGS1—skin of body—breast cancer	0.000244	0.0098	CbGeAlD
Rosiglitazone—CYP2C8—female reproductive system—breast cancer	0.000235	0.00944	CbGeAlD
Rosiglitazone—PTGS1—endometrium—breast cancer	0.00023	0.00924	CbGeAlD
Rosiglitazone—CYP2C19—endocrine gland—breast cancer	0.000228	0.00915	CbGeAlD
Rosiglitazone—PTGS1—uterus—breast cancer	0.000212	0.00851	CbGeAlD
Rosiglitazone—CYP2C9—female reproductive system—breast cancer	0.000209	0.00838	CbGeAlD
Rosiglitazone—PPARG—lymph node—breast cancer	0.000209	0.00837	CbGeAlD
Rosiglitazone—PTGS1—pituitary gland—breast cancer	0.000209	0.00836	CbGeAlD
Rosiglitazone—PTGS1—adipose tissue—breast cancer	0.000208	0.00833	CbGeAlD
Rosiglitazone—CYP2C8—endocrine gland—breast cancer	0.000199	0.00799	CbGeAlD
Rosiglitazone—ALB—lymph node—breast cancer	0.000196	0.00786	CbGeAlD
Rosiglitazone—PTGS1—female reproductive system—breast cancer	0.000191	0.00765	CbGeAlD
Rosiglitazone—CYP1A2—endocrine gland—breast cancer	0.000186	0.00747	CbGeAlD
Rosiglitazone—PTGS1—adrenal gland—breast cancer	0.000186	0.00747	CbGeAlD
Rosiglitazone—CYP2C9—endocrine gland—breast cancer	0.000177	0.00709	CbGeAlD
Rosiglitazone—PTGS1—female gonad—breast cancer	0.000174	0.00696	CbGeAlD
Rosiglitazone—PTGS1—endocrine gland—breast cancer	0.000162	0.00648	CbGeAlD
Rosiglitazone—CYP2D6—female reproductive system—breast cancer	0.000157	0.00629	CbGeAlD
Rosiglitazone—CYP2D6—female gonad—breast cancer	0.000143	0.00572	CbGeAlD
Rosiglitazone—Mepyramine—CYP2D6—breast cancer	0.000142	0.0529	CrCbGaD
Rosiglitazone—CYP2D6—endocrine gland—breast cancer	0.000133	0.00532	CbGeAlD
Rosiglitazone—Tripelennamine—CYP2D6—breast cancer	0.000132	0.049	CrCbGaD
Rosiglitazone—PTGS1—lymph node—breast cancer	0.000112	0.00448	CbGeAlD
Rosiglitazone—Rash—Tamoxifen—breast cancer	5.98e-05	0.000516	CcSEcCtD
Rosiglitazone—Dermatitis—Tamoxifen—breast cancer	5.97e-05	0.000515	CcSEcCtD
Rosiglitazone—Erythema multiforme—Capecitabine—breast cancer	5.96e-05	0.000514	CcSEcCtD
Rosiglitazone—Headache—Tamoxifen—breast cancer	5.94e-05	0.000512	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Gemcitabine—breast cancer	5.94e-05	0.000512	CcSEcCtD
Rosiglitazone—Eye disorder—Capecitabine—breast cancer	5.89e-05	0.000508	CcSEcCtD
Rosiglitazone—Immune system disorder—Docetaxel—breast cancer	5.88e-05	0.000507	CcSEcCtD
Rosiglitazone—Rash—Melphalan—breast cancer	5.85e-05	0.000505	CcSEcCtD
Rosiglitazone—Cardiac disorder—Capecitabine—breast cancer	5.85e-05	0.000505	CcSEcCtD
Rosiglitazone—Dermatitis—Melphalan—breast cancer	5.85e-05	0.000505	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Fluorouracil—breast cancer	5.84e-05	0.000504	CcSEcCtD
Rosiglitazone—Asthenia—Vinorelbine—breast cancer	5.82e-05	0.000502	CcSEcCtD
Rosiglitazone—Nausea—Vinblastine—breast cancer	5.8e-05	0.0005	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Irinotecan—breast cancer	5.78e-05	0.000498	CcSEcCtD
Rosiglitazone—Hypertension—Paclitaxel—breast cancer	5.77e-05	0.000498	CcSEcCtD
Rosiglitazone—Fatigue—Irinotecan—breast cancer	5.77e-05	0.000498	CcSEcCtD
Rosiglitazone—Fatigue—Mitoxantrone—breast cancer	5.77e-05	0.000498	CcSEcCtD
Rosiglitazone—Pruritus—Vinorelbine—breast cancer	5.74e-05	0.000495	CcSEcCtD
Rosiglitazone—Constipation—Mitoxantrone—breast cancer	5.72e-05	0.000494	CcSEcCtD
Rosiglitazone—Constipation—Irinotecan—breast cancer	5.72e-05	0.000494	CcSEcCtD
Rosiglitazone—Rash—Goserelin—breast cancer	5.71e-05	0.000493	CcSEcCtD
Rosiglitazone—Dermatitis—Goserelin—breast cancer	5.71e-05	0.000492	CcSEcCtD
Rosiglitazone—Immune system disorder—Capecitabine—breast cancer	5.69e-05	0.000491	CcSEcCtD
Rosiglitazone—Arthralgia—Paclitaxel—breast cancer	5.69e-05	0.000491	CcSEcCtD
Rosiglitazone—Myalgia—Paclitaxel—breast cancer	5.69e-05	0.000491	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Epirubicin—breast cancer	5.68e-05	0.00049	CcSEcCtD
Rosiglitazone—Headache—Goserelin—breast cancer	5.67e-05	0.000489	CcSEcCtD
Rosiglitazone—Malnutrition—Docetaxel—breast cancer	5.67e-05	0.000489	CcSEcCtD
Rosiglitazone—Nausea—Tamoxifen—breast cancer	5.63e-05	0.000486	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Gemcitabine—breast cancer	5.63e-05	0.000485	CcSEcCtD
Rosiglitazone—Fatigue—Gemcitabine—breast cancer	5.62e-05	0.000485	CcSEcCtD
Rosiglitazone—Constipation—Gemcitabine—breast cancer	5.57e-05	0.000481	CcSEcCtD
Rosiglitazone—Asthenia—Thiotepa—breast cancer	5.56e-05	0.000479	CcSEcCtD
Rosiglitazone—Diarrhoea—Vinorelbine—breast cancer	5.55e-05	0.000479	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Fluorouracil—breast cancer	5.53e-05	0.000477	CcSEcCtD
Rosiglitazone—Nausea—Melphalan—breast cancer	5.52e-05	0.000476	CcSEcCtD
Rosiglitazone—Malnutrition—Capecitabine—breast cancer	5.49e-05	0.000473	CcSEcCtD
Rosiglitazone—Back pain—Docetaxel—breast cancer	5.48e-05	0.000473	CcSEcCtD
Rosiglitazone—Pruritus—Thiotepa—breast cancer	5.48e-05	0.000473	CcSEcCtD
Rosiglitazone—Oedema—Paclitaxel—breast cancer	5.46e-05	0.000471	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Paclitaxel—breast cancer	5.46e-05	0.000471	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Methotrexate—breast cancer	5.45e-05	0.00047	CcSEcCtD
Rosiglitazone—Infection—Paclitaxel—breast cancer	5.42e-05	0.000468	CcSEcCtD
Rosiglitazone—Nausea—Goserelin—breast cancer	5.38e-05	0.000464	CcSEcCtD
Rosiglitazone—Dizziness—Vinorelbine—breast cancer	5.36e-05	0.000463	CcSEcCtD
Rosiglitazone—Nervous system disorder—Paclitaxel—breast cancer	5.35e-05	0.000462	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Paclitaxel—breast cancer	5.34e-05	0.000461	CcSEcCtD
Rosiglitazone—Urticaria—Mitoxantrone—breast cancer	5.31e-05	0.000458	CcSEcCtD
Rosiglitazone—Back pain—Capecitabine—breast cancer	5.31e-05	0.000458	CcSEcCtD
Rosiglitazone—Diarrhoea—Thiotepa—breast cancer	5.3e-05	0.000457	CcSEcCtD
Rosiglitazone—Nasopharyngitis—Doxorubicin—breast cancer	5.25e-05	0.000453	CcSEcCtD
Rosiglitazone—Anaemia—Docetaxel—breast cancer	5.24e-05	0.000452	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Methotrexate—breast cancer	5.18e-05	0.000447	CcSEcCtD
Rosiglitazone—Dizziness—Thiotepa—breast cancer	5.12e-05	0.000442	CcSEcCtD
Rosiglitazone—Rash—Vinorelbine—breast cancer	5.11e-05	0.000441	CcSEcCtD
Rosiglitazone—Dermatitis—Vinorelbine—breast cancer	5.11e-05	0.000441	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Epirubicin—breast cancer	5.1e-05	0.00044	CcSEcCtD
Rosiglitazone—Urticaria—Fluorouracil—breast cancer	5.09e-05	0.000439	CcSEcCtD
Rosiglitazone—Headache—Vinorelbine—breast cancer	5.08e-05	0.000438	CcSEcCtD
Rosiglitazone—Leukopenia—Docetaxel—breast cancer	5.07e-05	0.000438	CcSEcCtD
Rosiglitazone—Anaemia—Capecitabine—breast cancer	5.07e-05	0.000437	CcSEcCtD
Rosiglitazone—Weight increased—Epirubicin—breast cancer	4.99e-05	0.000431	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Paclitaxel—breast cancer	4.97e-05	0.000429	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Epirubicin—breast cancer	4.95e-05	0.000427	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Methotrexate—breast cancer	4.94e-05	0.000426	CcSEcCtD
Rosiglitazone—Leukopenia—Capecitabine—breast cancer	4.91e-05	0.000424	CcSEcCtD
Rosiglitazone—Hypertension—Docetaxel—breast cancer	4.89e-05	0.000422	CcSEcCtD
Rosiglitazone—Rash—Thiotepa—breast cancer	4.88e-05	0.000421	CcSEcCtD
Rosiglitazone—Dermatitis—Thiotepa—breast cancer	4.88e-05	0.000421	CcSEcCtD
Rosiglitazone—Headache—Thiotepa—breast cancer	4.85e-05	0.000419	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Epirubicin—breast cancer	4.85e-05	0.000418	CcSEcCtD
Rosiglitazone—Arthralgia—Docetaxel—breast cancer	4.82e-05	0.000416	CcSEcCtD
Rosiglitazone—Myalgia—Docetaxel—breast cancer	4.82e-05	0.000416	CcSEcCtD
Rosiglitazone—Nausea—Vinorelbine—breast cancer	4.82e-05	0.000416	CcSEcCtD
Rosiglitazone—Asthenia—Irinotecan—breast cancer	4.8e-05	0.000414	CcSEcCtD
Rosiglitazone—Asthenia—Mitoxantrone—breast cancer	4.8e-05	0.000414	CcSEcCtD
Rosiglitazone—Hypertension—Capecitabine—breast cancer	4.74e-05	0.000409	CcSEcCtD
Rosiglitazone—Upper respiratory tract infection—Doxorubicin—breast cancer	4.72e-05	0.000407	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Paclitaxel—breast cancer	4.71e-05	0.000406	CcSEcCtD
Rosiglitazone—Fatigue—Paclitaxel—breast cancer	4.7e-05	0.000406	CcSEcCtD
Rosiglitazone—Hepatitis—Methotrexate—breast cancer	4.69e-05	0.000405	CcSEcCtD
Rosiglitazone—Asthenia—Gemcitabine—breast cancer	4.68e-05	0.000403	CcSEcCtD
Rosiglitazone—Arthralgia—Capecitabine—breast cancer	4.67e-05	0.000403	CcSEcCtD
Rosiglitazone—Myalgia—Capecitabine—breast cancer	4.67e-05	0.000403	CcSEcCtD
Rosiglitazone—Constipation—Paclitaxel—breast cancer	4.67e-05	0.000402	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Epirubicin—breast cancer	4.63e-05	0.000399	CcSEcCtD
Rosiglitazone—Oedema—Docetaxel—breast cancer	4.62e-05	0.000399	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Docetaxel—breast cancer	4.62e-05	0.000399	CcSEcCtD
Rosiglitazone—Weight increased—Doxorubicin—breast cancer	4.62e-05	0.000398	CcSEcCtD
Rosiglitazone—Pruritus—Gemcitabine—breast cancer	4.61e-05	0.000398	CcSEcCtD
Rosiglitazone—Nausea—Thiotepa—breast cancer	4.6e-05	0.000397	CcSEcCtD
Rosiglitazone—Infection—Docetaxel—breast cancer	4.59e-05	0.000396	CcSEcCtD
Rosiglitazone—Sinusitis—Epirubicin—breast cancer	4.59e-05	0.000396	CcSEcCtD
Rosiglitazone—Hyperglycaemia—Doxorubicin—breast cancer	4.58e-05	0.000395	CcSEcCtD
Rosiglitazone—Diarrhoea—Mitoxantrone—breast cancer	4.58e-05	0.000395	CcSEcCtD
Rosiglitazone—Diarrhoea—Irinotecan—breast cancer	4.58e-05	0.000395	CcSEcCtD
Rosiglitazone—Nervous system disorder—Docetaxel—breast cancer	4.54e-05	0.000391	CcSEcCtD
Rosiglitazone—Pruritus—Fluorouracil—breast cancer	4.53e-05	0.000391	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Docetaxel—breast cancer	4.53e-05	0.000391	CcSEcCtD
Rosiglitazone—Stevens-Johnson syndrome—Doxorubicin—breast cancer	4.49e-05	0.000387	CcSEcCtD
Rosiglitazone—Oedema—Capecitabine—breast cancer	4.48e-05	0.000386	CcSEcCtD
Rosiglitazone—Diarrhoea—Gemcitabine—breast cancer	4.46e-05	0.000385	CcSEcCtD
Rosiglitazone—Infection—Capecitabine—breast cancer	4.45e-05	0.000384	CcSEcCtD
Rosiglitazone—Erythema multiforme—Methotrexate—breast cancer	4.44e-05	0.000383	CcSEcCtD
Rosiglitazone—Dizziness—Irinotecan—breast cancer	4.42e-05	0.000382	CcSEcCtD
Rosiglitazone—Nervous system disorder—Capecitabine—breast cancer	4.39e-05	0.000379	CcSEcCtD
Rosiglitazone—Hepatitis—Epirubicin—breast cancer	4.39e-05	0.000379	CcSEcCtD
Rosiglitazone—Eye disorder—Methotrexate—breast cancer	4.38e-05	0.000378	CcSEcCtD
Rosiglitazone—Diarrhoea—Fluorouracil—breast cancer	4.38e-05	0.000378	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Capecitabine—breast cancer	4.38e-05	0.000378	CcSEcCtD
Rosiglitazone—Cardiac disorder—Methotrexate—breast cancer	4.35e-05	0.000376	CcSEcCtD
Rosiglitazone—Urticaria—Paclitaxel—breast cancer	4.33e-05	0.000374	CcSEcCtD
Rosiglitazone—Oedema peripheral—Epirubicin—breast cancer	4.33e-05	0.000373	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Epirubicin—breast cancer	4.31e-05	0.000372	CcSEcCtD
Rosiglitazone—Hepatobiliary disease—Doxorubicin—breast cancer	4.28e-05	0.000369	CcSEcCtD
Rosiglitazone—Sinusitis—Doxorubicin—breast cancer	4.25e-05	0.000366	CcSEcCtD
Rosiglitazone—Immune system disorder—Methotrexate—breast cancer	4.24e-05	0.000366	CcSEcCtD
Rosiglitazone—Dizziness—Fluorouracil—breast cancer	4.24e-05	0.000366	CcSEcCtD
Rosiglitazone—Rash—Mitoxantrone—breast cancer	4.22e-05	0.000364	CcSEcCtD
Rosiglitazone—Rash—Irinotecan—breast cancer	4.22e-05	0.000364	CcSEcCtD
Rosiglitazone—Dermatitis—Mitoxantrone—breast cancer	4.21e-05	0.000364	CcSEcCtD
Rosiglitazone—Dermatitis—Irinotecan—breast cancer	4.21e-05	0.000364	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Docetaxel—breast cancer	4.21e-05	0.000363	CcSEcCtD
Rosiglitazone—Headache—Mitoxantrone—breast cancer	4.19e-05	0.000362	CcSEcCtD
Rosiglitazone—Headache—Irinotecan—breast cancer	4.19e-05	0.000362	CcSEcCtD
Rosiglitazone—Erythema multiforme—Epirubicin—breast cancer	4.15e-05	0.000358	CcSEcCtD
Rosiglitazone—Rash—Gemcitabine—breast cancer	4.11e-05	0.000354	CcSEcCtD
Rosiglitazone—Dermatitis—Gemcitabine—breast cancer	4.11e-05	0.000354	CcSEcCtD
Rosiglitazone—Eye disorder—Epirubicin—breast cancer	4.1e-05	0.000354	CcSEcCtD
Rosiglitazone—Malnutrition—Methotrexate—breast cancer	4.08e-05	0.000352	CcSEcCtD
Rosiglitazone—Headache—Gemcitabine—breast cancer	4.08e-05	0.000352	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Capecitabine—breast cancer	4.08e-05	0.000352	CcSEcCtD
Rosiglitazone—Cardiac disorder—Epirubicin—breast cancer	4.07e-05	0.000352	CcSEcCtD
Rosiglitazone—Hepatitis—Doxorubicin—breast cancer	4.06e-05	0.00035	CcSEcCtD
Rosiglitazone—Rash—Fluorouracil—breast cancer	4.04e-05	0.000349	CcSEcCtD
Rosiglitazone—Dermatitis—Fluorouracil—breast cancer	4.04e-05	0.000348	CcSEcCtD
Rosiglitazone—Headache—Fluorouracil—breast cancer	4.01e-05	0.000346	CcSEcCtD
Rosiglitazone—Oedema peripheral—Doxorubicin—breast cancer	4e-05	0.000345	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Docetaxel—breast cancer	3.99e-05	0.000344	CcSEcCtD
Rosiglitazone—Connective tissue disorder—Doxorubicin—breast cancer	3.99e-05	0.000344	CcSEcCtD
Rosiglitazone—Fatigue—Docetaxel—breast cancer	3.99e-05	0.000344	CcSEcCtD
Rosiglitazone—Nausea—Mitoxantrone—breast cancer	3.97e-05	0.000343	CcSEcCtD
Rosiglitazone—Nausea—Irinotecan—breast cancer	3.97e-05	0.000343	CcSEcCtD
Rosiglitazone—Immune system disorder—Epirubicin—breast cancer	3.97e-05	0.000342	CcSEcCtD
Rosiglitazone—Constipation—Docetaxel—breast cancer	3.95e-05	0.000341	CcSEcCtD
Rosiglitazone—Back pain—Methotrexate—breast cancer	3.95e-05	0.000341	CcSEcCtD
Rosiglitazone—Asthenia—Paclitaxel—breast cancer	3.91e-05	0.000338	CcSEcCtD
Rosiglitazone—Nausea—Gemcitabine—breast cancer	3.87e-05	0.000334	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Capecitabine—breast cancer	3.87e-05	0.000333	CcSEcCtD
Rosiglitazone—Fatigue—Capecitabine—breast cancer	3.86e-05	0.000333	CcSEcCtD
Rosiglitazone—Pruritus—Paclitaxel—breast cancer	3.86e-05	0.000333	CcSEcCtD
Rosiglitazone—Erythema multiforme—Doxorubicin—breast cancer	3.84e-05	0.000331	CcSEcCtD
Rosiglitazone—Constipation—Capecitabine—breast cancer	3.83e-05	0.00033	CcSEcCtD
Rosiglitazone—Malnutrition—Epirubicin—breast cancer	3.82e-05	0.00033	CcSEcCtD
Rosiglitazone—Nausea—Fluorouracil—breast cancer	3.81e-05	0.000328	CcSEcCtD
Rosiglitazone—Eye disorder—Doxorubicin—breast cancer	3.8e-05	0.000327	CcSEcCtD
Rosiglitazone—Anaemia—Methotrexate—breast cancer	3.77e-05	0.000326	CcSEcCtD
Rosiglitazone—Cardiac disorder—Doxorubicin—breast cancer	3.77e-05	0.000325	CcSEcCtD
Rosiglitazone—Diarrhoea—Paclitaxel—breast cancer	3.73e-05	0.000322	CcSEcCtD
Rosiglitazone—Back pain—Epirubicin—breast cancer	3.7e-05	0.000319	CcSEcCtD
Rosiglitazone—Immune system disorder—Doxorubicin—breast cancer	3.67e-05	0.000317	CcSEcCtD
Rosiglitazone—Leukopenia—Methotrexate—breast cancer	3.66e-05	0.000315	CcSEcCtD
Rosiglitazone—Dizziness—Paclitaxel—breast cancer	3.61e-05	0.000311	CcSEcCtD
Rosiglitazone—Urticaria—Capecitabine—breast cancer	3.56e-05	0.000307	CcSEcCtD
Rosiglitazone—Malnutrition—Doxorubicin—breast cancer	3.54e-05	0.000305	CcSEcCtD
Rosiglitazone—Anaemia—Epirubicin—breast cancer	3.53e-05	0.000305	CcSEcCtD
Rosiglitazone—Myalgia—Methotrexate—breast cancer	3.48e-05	0.0003	CcSEcCtD
Rosiglitazone—Arthralgia—Methotrexate—breast cancer	3.48e-05	0.0003	CcSEcCtD
Rosiglitazone—Rash—Paclitaxel—breast cancer	3.44e-05	0.000297	CcSEcCtD
Rosiglitazone—Dermatitis—Paclitaxel—breast cancer	3.44e-05	0.000296	CcSEcCtD
Rosiglitazone—Leukopenia—Epirubicin—breast cancer	3.42e-05	0.000295	CcSEcCtD
Rosiglitazone—Back pain—Doxorubicin—breast cancer	3.42e-05	0.000295	CcSEcCtD
Rosiglitazone—Headache—Paclitaxel—breast cancer	3.42e-05	0.000295	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Methotrexate—breast cancer	3.33e-05	0.000288	CcSEcCtD
Rosiglitazone—Asthenia—Docetaxel—breast cancer	3.32e-05	0.000286	CcSEcCtD
Rosiglitazone—Infection—Methotrexate—breast cancer	3.31e-05	0.000286	CcSEcCtD
Rosiglitazone—Hypertension—Epirubicin—breast cancer	3.3e-05	0.000285	CcSEcCtD
Rosiglitazone—Pruritus—Docetaxel—breast cancer	3.27e-05	0.000282	CcSEcCtD
Rosiglitazone—Nervous system disorder—Methotrexate—breast cancer	3.27e-05	0.000282	CcSEcCtD
Rosiglitazone—Anaemia—Doxorubicin—breast cancer	3.27e-05	0.000282	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Methotrexate—breast cancer	3.26e-05	0.000282	CcSEcCtD
Rosiglitazone—Myalgia—Epirubicin—breast cancer	3.25e-05	0.000281	CcSEcCtD
Rosiglitazone—Arthralgia—Epirubicin—breast cancer	3.25e-05	0.000281	CcSEcCtD
Rosiglitazone—Nausea—Paclitaxel—breast cancer	3.24e-05	0.00028	CcSEcCtD
Rosiglitazone—Asthenia—Capecitabine—breast cancer	3.21e-05	0.000277	CcSEcCtD
Rosiglitazone—Pruritus—Capecitabine—breast cancer	3.17e-05	0.000273	CcSEcCtD
Rosiglitazone—Leukopenia—Doxorubicin—breast cancer	3.17e-05	0.000273	CcSEcCtD
Rosiglitazone—Diarrhoea—Docetaxel—breast cancer	3.16e-05	0.000273	CcSEcCtD
Rosiglitazone—Oedema—Epirubicin—breast cancer	3.12e-05	0.000269	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Epirubicin—breast cancer	3.12e-05	0.000269	CcSEcCtD
Rosiglitazone—Infection—Epirubicin—breast cancer	3.1e-05	0.000267	CcSEcCtD
Rosiglitazone—Diarrhoea—Capecitabine—breast cancer	3.06e-05	0.000264	CcSEcCtD
Rosiglitazone—Nervous system disorder—Epirubicin—breast cancer	3.06e-05	0.000264	CcSEcCtD
Rosiglitazone—Dizziness—Docetaxel—breast cancer	3.06e-05	0.000264	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Epirubicin—breast cancer	3.05e-05	0.000263	CcSEcCtD
Rosiglitazone—Hypertension—Doxorubicin—breast cancer	3.05e-05	0.000263	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Methotrexate—breast cancer	3.04e-05	0.000262	CcSEcCtD
Rosiglitazone—Arthralgia—Doxorubicin—breast cancer	3.01e-05	0.00026	CcSEcCtD
Rosiglitazone—Myalgia—Doxorubicin—breast cancer	3.01e-05	0.00026	CcSEcCtD
Rosiglitazone—Dizziness—Capecitabine—breast cancer	2.96e-05	0.000255	CcSEcCtD
Rosiglitazone—Rash—Docetaxel—breast cancer	2.92e-05	0.000252	CcSEcCtD
Rosiglitazone—Dermatitis—Docetaxel—breast cancer	2.91e-05	0.000251	CcSEcCtD
Rosiglitazone—Headache—Docetaxel—breast cancer	2.9e-05	0.00025	CcSEcCtD
Rosiglitazone—Oedema—Doxorubicin—breast cancer	2.89e-05	0.000249	CcSEcCtD
Rosiglitazone—Anaphylactic shock—Doxorubicin—breast cancer	2.89e-05	0.000249	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Methotrexate—breast cancer	2.88e-05	0.000248	CcSEcCtD
Rosiglitazone—Fatigue—Methotrexate—breast cancer	2.87e-05	0.000248	CcSEcCtD
Rosiglitazone—Infection—Doxorubicin—breast cancer	2.87e-05	0.000247	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Epirubicin—breast cancer	2.84e-05	0.000245	CcSEcCtD
Rosiglitazone—Nervous system disorder—Doxorubicin—breast cancer	2.83e-05	0.000244	CcSEcCtD
Rosiglitazone—Thrombocytopenia—Doxorubicin—breast cancer	2.83e-05	0.000244	CcSEcCtD
Rosiglitazone—Rash—Capecitabine—breast cancer	2.82e-05	0.000244	CcSEcCtD
Rosiglitazone—Dermatitis—Capecitabine—breast cancer	2.82e-05	0.000243	CcSEcCtD
Rosiglitazone—Headache—Capecitabine—breast cancer	2.81e-05	0.000242	CcSEcCtD
Rosiglitazone—Nausea—Docetaxel—breast cancer	2.75e-05	0.000237	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Epirubicin—breast cancer	2.69e-05	0.000232	CcSEcCtD
Rosiglitazone—Fatigue—Epirubicin—breast cancer	2.69e-05	0.000232	CcSEcCtD
Rosiglitazone—Constipation—Epirubicin—breast cancer	2.67e-05	0.00023	CcSEcCtD
Rosiglitazone—Nausea—Capecitabine—breast cancer	2.66e-05	0.000229	CcSEcCtD
Rosiglitazone—Urticaria—Methotrexate—breast cancer	2.65e-05	0.000228	CcSEcCtD
Rosiglitazone—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.63e-05	0.000227	CcSEcCtD
Rosiglitazone—Gastrointestinal disorder—Doxorubicin—breast cancer	2.49e-05	0.000215	CcSEcCtD
Rosiglitazone—Fatigue—Doxorubicin—breast cancer	2.49e-05	0.000215	CcSEcCtD
Rosiglitazone—Urticaria—Epirubicin—breast cancer	2.48e-05	0.000214	CcSEcCtD
Rosiglitazone—Constipation—Doxorubicin—breast cancer	2.47e-05	0.000213	CcSEcCtD
Rosiglitazone—Asthenia—Methotrexate—breast cancer	2.39e-05	0.000206	CcSEcCtD
Rosiglitazone—Pruritus—Methotrexate—breast cancer	2.36e-05	0.000203	CcSEcCtD
Rosiglitazone—Urticaria—Doxorubicin—breast cancer	2.29e-05	0.000198	CcSEcCtD
Rosiglitazone—Diarrhoea—Methotrexate—breast cancer	2.28e-05	0.000197	CcSEcCtD
Rosiglitazone—Asthenia—Epirubicin—breast cancer	2.24e-05	0.000193	CcSEcCtD
Rosiglitazone—Pruritus—Epirubicin—breast cancer	2.21e-05	0.00019	CcSEcCtD
Rosiglitazone—Dizziness—Methotrexate—breast cancer	2.2e-05	0.00019	CcSEcCtD
Rosiglitazone—Diarrhoea—Epirubicin—breast cancer	2.13e-05	0.000184	CcSEcCtD
Rosiglitazone—Rash—Methotrexate—breast cancer	2.1e-05	0.000181	CcSEcCtD
Rosiglitazone—Dermatitis—Methotrexate—breast cancer	2.1e-05	0.000181	CcSEcCtD
Rosiglitazone—Headache—Methotrexate—breast cancer	2.09e-05	0.00018	CcSEcCtD
Rosiglitazone—Asthenia—Doxorubicin—breast cancer	2.07e-05	0.000179	CcSEcCtD
Rosiglitazone—Dizziness—Epirubicin—breast cancer	2.06e-05	0.000178	CcSEcCtD
Rosiglitazone—Pruritus—Doxorubicin—breast cancer	2.04e-05	0.000176	CcSEcCtD
Rosiglitazone—Nausea—Methotrexate—breast cancer	1.98e-05	0.000171	CcSEcCtD
Rosiglitazone—Diarrhoea—Doxorubicin—breast cancer	1.97e-05	0.00017	CcSEcCtD
Rosiglitazone—Rash—Epirubicin—breast cancer	1.97e-05	0.00017	CcSEcCtD
Rosiglitazone—Dermatitis—Epirubicin—breast cancer	1.96e-05	0.00017	CcSEcCtD
Rosiglitazone—Headache—Epirubicin—breast cancer	1.95e-05	0.000169	CcSEcCtD
Rosiglitazone—Dizziness—Doxorubicin—breast cancer	1.91e-05	0.000165	CcSEcCtD
Rosiglitazone—Nausea—Epirubicin—breast cancer	1.85e-05	0.00016	CcSEcCtD
Rosiglitazone—Rash—Doxorubicin—breast cancer	1.82e-05	0.000157	CcSEcCtD
Rosiglitazone—Dermatitis—Doxorubicin—breast cancer	1.82e-05	0.000157	CcSEcCtD
Rosiglitazone—Headache—Doxorubicin—breast cancer	1.81e-05	0.000156	CcSEcCtD
Rosiglitazone—Nausea—Doxorubicin—breast cancer	1.71e-05	0.000148	CcSEcCtD
Rosiglitazone—CYP2C19—Metabolism—NQO1—breast cancer	2.4e-06	3.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NCOA2—breast cancer	2.39e-06	3.06e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—MYC—breast cancer	2.39e-06	3.06e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.39e-06	3.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NCOA2—breast cancer	2.37e-06	3.03e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CG—breast cancer	2.36e-06	3.03e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CPT1A—breast cancer	2.36e-06	3.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTR—breast cancer	2.36e-06	3.02e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCG2—breast cancer	2.36e-06	3.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.35e-06	3e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CD—breast cancer	2.34e-06	2.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP3A4—breast cancer	2.34e-06	2.99e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.32e-06	2.97e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—FASN—breast cancer	2.32e-06	2.97e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HPGDS—breast cancer	2.32e-06	2.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—BCHE—breast cancer	2.31e-06	2.96e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—ALB—breast cancer	2.31e-06	2.95e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HBA1—breast cancer	2.3e-06	2.94e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—SRC—breast cancer	2.3e-06	2.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—FASN—breast cancer	2.3e-06	2.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1B1—breast cancer	2.3e-06	2.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—BCHE—breast cancer	2.29e-06	2.93e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC5A5—breast cancer	2.28e-06	2.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.27e-06	2.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC5A5—breast cancer	2.26e-06	2.89e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.26e-06	2.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HSP90AA1—breast cancer	2.25e-06	2.88e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—COMT—breast cancer	2.25e-06	2.88e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTT1—breast cancer	2.25e-06	2.87e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ACHE—breast cancer	2.25e-06	2.87e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—VEGFA—breast cancer	2.24e-06	2.87e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTP1—breast cancer	2.24e-06	2.86e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—COMT—breast cancer	2.24e-06	2.86e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CG—breast cancer	2.24e-06	2.86e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PTEN—breast cancer	2.23e-06	2.86e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTP1—breast cancer	2.23e-06	2.85e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—HMOX1—breast cancer	2.21e-06	2.83e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—NOS3—breast cancer	2.21e-06	2.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NQO1—breast cancer	2.2e-06	2.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—SLC2A1—breast cancer	2.2e-06	2.82e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ITPR1—breast cancer	2.2e-06	2.82e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—HMOX1—breast cancer	2.19e-06	2.81e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NCOA1—breast cancer	2.19e-06	2.8e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ITPR1—breast cancer	2.19e-06	2.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NQO1—breast cancer	2.18e-06	2.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—SLC2A1—breast cancer	2.18e-06	2.8e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—STK11—breast cancer	2.16e-06	2.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP19A1—breast cancer	2.16e-06	2.76e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP3A4—breast cancer	2.15e-06	2.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.14e-06	2.74e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP3A4—breast cancer	2.13e-06	2.73e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP17A1—breast cancer	2.13e-06	2.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.12e-06	2.71e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—MAPK3—breast cancer	2.12e-06	2.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ABCB1—breast cancer	2.12e-06	2.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1B1—breast cancer	2.11e-06	2.7e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ABCB1—breast cancer	2.11e-06	2.7e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ENO1—breast cancer	2.1e-06	2.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS1—breast cancer	2.1e-06	2.69e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.1e-06	2.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1B1—breast cancer	2.09e-06	2.68e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—TYMS—breast cancer	2.08e-06	2.66e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CD—breast cancer	2.08e-06	2.66e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.07e-06	2.65e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.07e-06	2.65e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—TYMS—breast cancer	2.07e-06	2.65e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP2D6—breast cancer	2.06e-06	2.64e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GSTM1—breast cancer	2.06e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PLA2G4A—breast cancer	2.06e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NCOR1—breast cancer	2.06e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TGFB1—breast cancer	2.06e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HSP90AA1—breast cancer	2.05e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—ALB—breast cancer	2.05e-06	2.63e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PLA2G4A—breast cancer	2.05e-06	2.62e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NCOR1—breast cancer	2.05e-06	2.62e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GSTM1—breast cancer	2.05e-06	2.62e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CB—breast cancer	2.04e-06	2.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—breast cancer	2.03e-06	2.59e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NCOA2—breast cancer	2.03e-06	2.59e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTGS2—breast cancer	2.02e-06	2.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NCOA1—breast cancer	2.02e-06	2.58e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—COMT—breast cancer	2.01e-06	2.57e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTP1—breast cancer	2e-06	2.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NCOA1—breast cancer	2e-06	2.56e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—STK11—breast cancer	1.99e-06	2.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP19A1—breast cancer	1.99e-06	2.54e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—HMOX1—breast cancer	1.97e-06	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—GPX1—breast cancer	1.97e-06	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP19A1—breast cancer	1.97e-06	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—STK11—breast cancer	1.97e-06	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ITPR1—breast cancer	1.97e-06	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CD—breast cancer	1.97e-06	2.52e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—FASN—breast cancer	1.96e-06	2.51e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—NOS3—breast cancer	1.96e-06	2.51e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—GPX1—breast cancer	1.96e-06	2.51e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—BCHE—breast cancer	1.96e-06	2.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CYP1A1—breast cancer	1.95e-06	2.5e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—ALB—breast cancer	1.94e-06	2.48e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CYP1A1—breast cancer	1.94e-06	2.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ERCC2—breast cancer	1.93e-06	2.47e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC5A5—breast cancer	1.93e-06	2.47e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—ERCC2—breast cancer	1.92e-06	2.46e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—KRAS—breast cancer	1.9e-06	2.44e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ABCB1—breast cancer	1.89e-06	2.42e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—SLC2A1—breast cancer	1.87e-06	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NQO1—breast cancer	1.87e-06	2.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—TYMS—breast cancer	1.86e-06	2.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—NOS3—breast cancer	1.86e-06	2.38e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.85e-06	2.37e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—COMT—breast cancer	1.85e-06	2.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTP1—breast cancer	1.84e-06	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PLA2G4A—breast cancer	1.84e-06	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NCOR1—breast cancer	1.84e-06	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GSTM1—breast cancer	1.84e-06	2.35e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—COMT—breast cancer	1.83e-06	2.34e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.83e-06	2.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTP1—breast cancer	1.82e-06	2.33e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP3A4—breast cancer	1.82e-06	2.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—MTHFR—breast cancer	1.82e-06	2.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—HMOX1—breast cancer	1.81e-06	2.32e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CB—breast cancer	1.81e-06	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.81e-06	2.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ITPR1—breast cancer	1.81e-06	2.31e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—MTHFR—breast cancer	1.81e-06	2.31e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—HMOX1—breast cancer	1.8e-06	2.3e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTGS2—breast cancer	1.8e-06	2.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ITPR1—breast cancer	1.79e-06	2.29e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP1B1—breast cancer	1.79e-06	2.29e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PTEN—breast cancer	1.76e-06	2.25e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—GPX1—breast cancer	1.76e-06	2.25e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HSP90AA1—breast cancer	1.75e-06	2.25e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—PIK3CA—breast cancer	1.75e-06	2.24e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CYP1A1—breast cancer	1.74e-06	2.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ABCB1—breast cancer	1.74e-06	2.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ERCC2—breast cancer	1.73e-06	2.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ABCB1—breast cancer	1.72e-06	2.21e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CB—breast cancer	1.71e-06	2.19e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—TYMS—breast cancer	1.71e-06	2.19e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NCOA1—breast cancer	1.71e-06	2.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTGS2—breast cancer	1.7e-06	2.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—TYMS—breast cancer	1.69e-06	2.17e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—TP53—breast cancer	1.69e-06	2.17e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NCOR1—breast cancer	1.69e-06	2.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GSTM1—breast cancer	1.69e-06	2.16e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PLA2G4A—breast cancer	1.69e-06	2.16e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—STK11—breast cancer	1.68e-06	2.15e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP19A1—breast cancer	1.68e-06	2.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—CAV1—breast cancer	1.68e-06	2.15e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GSTM1—breast cancer	1.67e-06	2.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NCOR1—breast cancer	1.67e-06	2.14e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PLA2G4A—breast cancer	1.67e-06	2.14e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—CAV1—breast cancer	1.67e-06	2.13e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Gene Expression—AKT1—breast cancer	1.66e-06	2.12e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—MTHFR—breast cancer	1.62e-06	2.08e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—HRAS—breast cancer	1.62e-06	2.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—GPX1—breast cancer	1.62e-06	2.07e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—GPX1—breast cancer	1.6e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.6e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CYP1A1—breast cancer	1.6e-06	2.05e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.59e-06	2.04e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ERCC2—breast cancer	1.59e-06	2.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CYP1A1—breast cancer	1.59e-06	2.03e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.58e-06	2.02e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—PIK3CA—breast cancer	1.58e-06	2.02e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ERCC2—breast cancer	1.57e-06	2.01e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PTEN—breast cancer	1.57e-06	2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—COMT—breast cancer	1.56e-06	2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTP1—breast cancer	1.56e-06	1.99e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—HMOX1—breast cancer	1.54e-06	1.96e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ITPR1—breast cancer	1.53e-06	1.96e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CG—breast cancer	1.53e-06	1.95e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CG—breast cancer	1.52e-06	1.94e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—CAV1—breast cancer	1.5e-06	1.92e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—MTHFR—breast cancer	1.49e-06	1.91e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PTEN—breast cancer	1.48e-06	1.89e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—MTHFR—breast cancer	1.48e-06	1.89e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ABCB1—breast cancer	1.47e-06	1.89e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—TYMS—breast cancer	1.45e-06	1.85e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NCOR1—breast cancer	1.43e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.43e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GSTM1—breast cancer	1.43e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.43e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—ALB—Hemostasis—AKT1—breast cancer	1.43e-06	1.83e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—CAV1—breast cancer	1.38e-06	1.76e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—GPX1—breast cancer	1.37e-06	1.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—CAV1—breast cancer	1.36e-06	1.75e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CG—breast cancer	1.36e-06	1.74e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CYP1A1—breast cancer	1.36e-06	1.74e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ERCC2—breast cancer	1.34e-06	1.72e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CD—breast cancer	1.34e-06	1.72e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CD—breast cancer	1.34e-06	1.71e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—ALB—breast cancer	1.33e-06	1.7e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.3e-06	1.67e-05	CbGpPWpGaD
Rosiglitazone—PPARG—Metabolism—AKT1—breast cancer	1.29e-06	1.65e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—NOS3—breast cancer	1.27e-06	1.62e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—MTHFR—breast cancer	1.26e-06	1.62e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—NOS3—breast cancer	1.26e-06	1.61e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CG—breast cancer	1.25e-06	1.6e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CG—breast cancer	1.24e-06	1.59e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—PIK3CA—breast cancer	1.24e-06	1.59e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CD—breast cancer	1.2e-06	1.53e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—ALB—breast cancer	1.18e-06	1.51e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CB—breast cancer	1.17e-06	1.5e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—CAV1—breast cancer	1.17e-06	1.49e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CB—breast cancer	1.16e-06	1.49e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTGS2—breast cancer	1.16e-06	1.48e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTGS2—breast cancer	1.15e-06	1.48e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—NOS3—breast cancer	1.13e-06	1.45e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.11e-06	1.43e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—PIK3CA—breast cancer	1.1e-06	1.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CD—breast cancer	1.1e-06	1.41e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CD—breast cancer	1.09e-06	1.4e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—ALB—breast cancer	1.09e-06	1.39e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—ALB—breast cancer	1.08e-06	1.38e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CG—breast cancer	1.06e-06	1.36e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CB—breast cancer	1.04e-06	1.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—PIK3CA—breast cancer	1.04e-06	1.34e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—NOS3—breast cancer	1.04e-06	1.33e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTGS2—breast cancer	1.04e-06	1.32e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—NOS3—breast cancer	1.03e-06	1.32e-05	CbGpPWpGaD
Rosiglitazone—SLCO1B1—Metabolism—AKT1—breast cancer	1.01e-06	1.3e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PTEN—breast cancer	1.01e-06	1.29e-05	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PTEN—breast cancer	1.01e-06	1.29e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CB—breast cancer	9.61e-07	1.23e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CB—breast cancer	9.52e-07	1.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTGS2—breast cancer	9.52e-07	1.22e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTGS2—breast cancer	9.44e-07	1.21e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CD—breast cancer	9.34e-07	1.2e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—ALB—breast cancer	9.22e-07	1.18e-05	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PTEN—breast cancer	9.03e-07	1.16e-05	CbGpPWpGaD
Rosiglitazone—PTGS1—Metabolism—AKT1—breast cancer	9.02e-07	1.15e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—NOS3—breast cancer	8.82e-07	1.13e-05	CbGpPWpGaD
Rosiglitazone—CYP2A6—Metabolism—AKT1—breast cancer	8.53e-07	1.09e-05	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PTEN—breast cancer	8.3e-07	1.06e-05	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PTEN—breast cancer	8.23e-07	1.05e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CB—breast cancer	8.14e-07	1.04e-05	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTGS2—breast cancer	8.06e-07	1.03e-05	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—PIK3CA—breast cancer	7.13e-07	9.13e-06	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—PIK3CA—breast cancer	7.09e-07	9.08e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PTEN—breast cancer	7.03e-07	9e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—PIK3CA—breast cancer	6.37e-07	8.15e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—PIK3CA—breast cancer	5.86e-07	7.5e-06	CbGpPWpGaD
Rosiglitazone—CYP2C8—Metabolism—AKT1—breast cancer	5.83e-07	7.46e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—PIK3CA—breast cancer	5.81e-07	7.43e-06	CbGpPWpGaD
Rosiglitazone—ALB—Metabolism—AKT1—breast cancer	5.79e-07	7.42e-06	CbGpPWpGaD
Rosiglitazone—CYP2C19—Metabolism—AKT1—breast cancer	5.2e-07	6.66e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—PIK3CA—breast cancer	4.96e-07	6.35e-06	CbGpPWpGaD
Rosiglitazone—CYP2D6—Metabolism—AKT1—breast cancer	4.78e-07	6.12e-06	CbGpPWpGaD
Rosiglitazone—CYP2C9—Metabolism—AKT1—breast cancer	4.74e-07	6.07e-06	CbGpPWpGaD
Rosiglitazone—CYP1A2—Metabolism—AKT1—breast cancer	4.05e-07	5.19e-06	CbGpPWpGaD
